Arnold Samuel L, Stevison Faith, Isoherranen Nina
Department of Pharmaceutics, University of Washington , Health Science Building, Room H-272M, Box 357610, Seattle, Washington 98195-7610, United States.
Anal Chem. 2016 Jan 5;88(1):746-53. doi: 10.1021/acs.analchem.5b03004. Epub 2015 Dec 14.
Protein quantification based on peptides using LC-MS/MS has emerged as a promising method to measure biomarkers, protein drugs, and endogenous proteins. However, the best practices for selection, optimization, and validation of the quantification peptides are not well established, and the influence of different matrices on protein digestion, peptide stability, and MS detection has not been systematically addressed. The aim of this study was to determine how biological matrices affect digestion, detection, and stability of peptides. The microsomal retinol dehydrogenase (RDH11) and cytosolic soluble aldehyde dehydrogenases (ALDH1As) involved in the synthesis of retinoic acid (RA) were chosen as model proteins. Considerable differences in the digestion efficiency, sensitivity, and matrix effects between peptides were observed regardless of the target protein's subcellular localization. The precision and accuracy of the quantification of RDH11 and ALDH1A were affected by the choice of calibration and internal standards. The final method using recombinant protein calibrators and stable isotope labeled (SIL) peptide internal standards was validated for human liver. The results demonstrate that different sample matrices have peptide, time, and matrix specific effects on protein digestion and absolute quantification.
基于肽段利用液相色谱-串联质谱(LC-MS/MS)进行蛋白质定量,已成为一种颇具前景的测量生物标志物、蛋白质药物和内源性蛋白质的方法。然而,定量肽段的选择、优化及验证的最佳实践尚未完全确立,且不同基质对蛋白质消化、肽段稳定性和质谱检测的影响也未得到系统研究。本研究的目的是确定生物基质如何影响肽段的消化、检测及稳定性。选择参与视黄酸(RA)合成的微粒体视黄醇脱氢酶(RDH11)和胞质可溶性醛脱氢酶(ALDH1As)作为模型蛋白。无论目标蛋白的亚细胞定位如何,肽段之间在消化效率、灵敏度和基质效应方面均观察到显著差异。RDH11和ALDH1A定量的精密度和准确度受校准品和内标选择的影响。使用重组蛋白校准品和稳定同位素标记(SIL)肽段内标的最终方法在人肝脏样本中得到验证。结果表明,不同的样本基质对蛋白质消化和绝对定量具有肽段特异性、时间特异性和基质特异性影响。